mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.3 |
2e-08 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.27 |
2e-06 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-05 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |